title: Denosumab-Associated Osteomyelitis of the Jaw in a Prostate Cancer Patient--Is This a New Beast?
authors.forename: Hugo
authors.initials: H
authors.lastname: Campos
authors.forename: Mina
authors.initials: M
authors.lastname: Mahdian
authors.forename: Upendra
authors.initials: U
authors.lastname: Hegde
authors.forename: Alan
authors.initials: A
authors.lastname: Lurie
authors.forename: Aditya
authors.initials: A
authors.lastname: Tadinada
mesh_terms: D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D000069448:Denosumab / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008336:Mandibular Diseases / Q000139:chemically induced*; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D010019:Osteomyelitis / Q000139:chemically induced*; D011471:Prostatic Neoplasms / Q000628:therapy*
chemical_list: D050071:Bone Density Conservation Agents; D000069448:Denosumab